Operating target therapy for cancer drugs, key success factors.

• Main Authors: Kuo-Yao Hung, 洪國耀
• Other Authors: Ying-Chun Li
• Format: Others
• Language: zh-TW
• Published: 2010
• Online Access: http://ndltd.ncl.edu.tw/handle/01138788477012113973

碩士 === 國立中山大學 === 高階經營碩士班 === 98 === Abstract Cancer has been a big issue in the medical science. Many scientists in the world have been trying so hard to find the effective drugs or therapies for different kinds of cancers. However, cancer is till so hard to cure. Until these days targeted therapies show up and give cancer patient a new hope to cure cancer. Targeted therapies are drugs which can block the growth and spread of cancer by interfering with specific molecules involved in tumor growth and progression. By focusing on molecular and cellular changes that are specific to cancer, targeted therapies are more effective than other types of treatment, including chemotherapy and radiotherapy, and less harmful to normal cells. Targeted therapies have been known by reducing side effects and improving quality life as well. Therefore, many drug manufactures have been investing money on investigating targeted therapies. Target therapy market is rapidly expending, and the competition among the drug manufactures has been more and fiercer. The key or critical success factors to the business of target cancer drugs are the most important issue for the drug manufactures to get the most profit from target drugs. The key success factors can be analyzed by sell strategy, research, development strategy, price strategy and government policy. This paper is trying to find the key success factors for business of target cancer drugs by deep interviewing the top sells managers in the industry and the top doctors in the hospital. Then these interview contents are analyzed by SWOT (strength, weakness, opportunity and threat) to find the key success factors for business of target cancer drugs. With these key success factors, hopefully it can help the drug manufactures make good business on target cancer drug market. Keywords: target drug, target therapy, key success factor, critical success factor, SWOT, deep interview.